Sientra says to resume selling its breast implant devices in US
February 08, 2016 at 09:28 AM EST
Feb 8 (Reuters) - Breast implant maker Sientra Inc said it will resume selling all of its medical devices in the U.S. market from March 1, four months after it suspended sales of its breast implant devices to ensure technical compliance.
